Skip to content
Main Navigation
About us
Company profile
Our values
Our strategy
Board of Directors
Senior management
Our history
Research and development
Technology platform
Therapeutic areas
Pipeline
Scientific papers and presentations
Partnering
Our approach
Our partnerships
Investors
Financial reports and presentations
Share information
Analyst coverage
Major shareholders
Financial calendar
Corporate governance
Corporate governance statements
Dividend policy
Annual general meeting
Articles of association
Safe harbour statement
Whistleblower policy
Risk management
Investor relations policy
ESG
Email alerts
Newsroom
Press Releases
Image library
Glossary
Email alerts
Careers
Life at Nykode
Meet us
Open positions
Search
Investors
Financial reports and presentations
Latest company presentation (PDF)
Newest first
Oldest first
Presentations
Financial reports
Webcasts
Search
Reset
17/02/2022
SVB Leerink 2022 Global Healthcare Conference – February 18, 2022
05/01/2022
Company update on T cell focused COVID-19 vaccine candidate
23/11/2021
Nykode Therapeutics company update – webcast
06/10/2021
Guggenheim Securities’ 2nd Annual Vaccine and Infectious Disease Days – October 6, 2021
26/08/2021
Vaccibody Q2 and half-year report 2021 – August 26 2021
Pages:
1
2
3
4
5
6
7
8
Load more
Sorry, nothing found in this query
Privacy statement
Cookie policy
Disclaimer
